MACI MCQUEARY: Open Payments
NPI 1104430297 · CAMPBELLSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 16 payments from 11 companies in 2025. Trend: 2023 $335 · 2024 $344 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $49 |
| Novo Nordisk Inc | 3 | $49 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Alkermes, Inc. | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| PFIZER INC. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Auvelity, VIVITROL, REXULTI, QULIPTA, VRAYLAR, TRINTELLIX, Ozempic, Wegovy.
Industry payments across KY — which companies pay providers there.
